Sera from HBV-HCC patients were characterized by higher MMP-2 and pentraxin-3 levels, with a trend toward lower cytokine and chemokine concentrations, when compared to HBV patients with cirrhosis (Figure 3B,C). Here, MMP2 is linked to Cirrhosis.